Jeremy M. Levin, CEO at Ovid Therapeutics Inc. (OVID), bought 30,668 shares at $7.15 ($219K) on 2017-08-25, disclosed to the SEC on 2017-08-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.15 | 15,334 | $110K | 50.0% |
| 2 | $7.15 | 15,334 | $110K | 50.0% |
| Total | $7.15 avg | 30,668 | $219K | 100% |
| Filing → |
| OVID | BUY | 2019-10-10 | $150K | — | Filing → |
| OVID | BUY | 2019-02-26 | $150K | — | Filing → |